BioSight
Companies
Celldex Therapeutics, Inc. logo

CLDX

NASDAQHAMPTON, NJ
Celldex Therapeutics, Inc.

Celldex Therapeutics develops drug candidates across multiple therapeutic areas using various modalities, with a pipeline at different stages of preclinical and clinical development. The company is focused on advancing product candidates through research, preclinical studies, and clinical trials with the goal of obtaining regulatory approvals and commercializing treatments. Celldex relies on strategic partnerships to support development of its drug candidates.

Price history not yet available for CLDX.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar